Mumbai’s cancer burden has grown sharply over recent decades, but the more pressing concern for the city’s healthcare system is that 53% of patients are still diagnosed after the disease has advanced, according to figures presented at a conclave marking the Indian Cancer Society’s 75th year.
Dr Vinay Deshmane, who oversees the society’s cancer registry, said Mumbai recorded 15,650 cancer cases in 2019, compared with 3,059 in 1964. The Times of India reported that the increase reflects population growth and longer life expectancy as well as the city’s changing demographic profile. People aged above 60 now account for nearly 56% of cancer cases, compared with 33% in 1964.
Deaths rose from 3,475 in 1989 to 7,563 in 2019. However, Mumbai’s age-adjusted mortality rate declined marginally from 61.3 to 57 per 1 lakh population over the period. The figures therefore do not, by themselves, establish that an individual’s cancer risk has risen at the same rate as the total number of cases.
Former Tata Memorial Hospital director Dr Rajendra Badwe said the higher numbers were largely linked to population size, noting that cancer incidence in urban India was about 110 per 1 lakh people, compared with 360 per 1 lakh in the United States. He also said awareness had improved, although not enough to ensure sufficiently early treatment.
There are signs that some patients are reaching care earlier. Dr Badwe said the average tumour size among women arriving at Tata Memorial Hospital had fallen from 6.4 cm earlier to 2.7 cm in recent years. He said patients should ideally seek medical help before a tumour grows beyond 1 cm.
The continuing prevalence of late diagnosis points to a gap between the availability of specialised treatment and people’s ability to recognise symptoms and reach appropriate facilities in time. Dr Deshmane attributed late presentation largely to limited awareness, while Tata Memorial Hospital director Dr Sudeep Gupta identified access to healthcare as a major barrier, particularly outside cities. He said some patients in parts of northern India make multiple trips to hospitals located 50 to 100 km from their homes.
The access challenge has prompted infrastructure planning in Maharashtra. Maharashtra Cancer Care CEO Dr Ajay Chandanwale said the state government had launched a programme to improve cancer-care infrastructure and planned to establish 19 cancer hospitals. The proposed network includes nine 150-bed facilities and 10 smaller 50-bed day-care centres.
The reported figures underline that cancer outcomes depend not only on treatment capacity but also on whether patients can identify warning signs and reach care before the disease advances. The state’s proposed facilities could expand the physical network, but the report does not provide implementation timelines or details on their locations, staffing and operating arrangements.


